Outcome Measures for Clinical Trials Assessing Treatment of Cystic Fibrosis Lung Disease

Clinical Investigation
doi 10.4155/cli.11.174
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Disease-Specific Clinical Trials Networks: The Example of Cystic Fibrosis

European Journal of Pediatrics
Child HealthPediatricsPerinatology
2016English

Imaging of Cystic Fibrosis Lung Disease and Clinical Interpretation

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren
MedicineNuclear MedicineRadiologyImaging
2016English

Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease

Genes
Genetics
2019English

Origins of Cystic Fibrosis Lung Disease

New England Journal of Medicine
Medicine
2015English

460. Lentiviral-Mediated ENaCα Knockdown, as a Treatment for Cystic Fibrosis Lung Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Challenges Facing microRNA Therapeutics for Cystic Fibrosis Lung Disease

Epigenomics
Cancer ResearchGenetics
2020English

CXCR1andCXCR2haplotypes Synergistically Modulate Cystic Fibrosis Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Elucidating Progression of Early Cystic Fibrosis Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

The Clinical Utility of Lung Clearance Index in Early Cystic Fibrosis Lung Disease Is Not Impacted by the Number of Multiple-Breath Washout Trials

ERJ Open Research
PulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy